Value through Innovation27 July 2016

Clinical Study Results

  • MENOFEM ® - Menopause
    Clinical Study Number 563.1
    Study Indication Menopause
    Product MENOFEM ®
    Generic Name Cimicifuga rhizome extract
    Lab Code
    Clinical Phase III
    Study Title

    Double-blind dose/response study comparing Klimadynon® with conjugated oestrogens in women suffering from menopausal complaints

    Study Document Trial synopsis 563.1 english
  • MENOFEM ® - Menopause
    Clinical Study Number 563.3
    Study Indication Menopause
    Product MENOFEM ®
    Generic Name Cimicifuga rhizome extract
    Lab Code
    Clinical Phase IV
    Study Title

    A prospective, open label, multicentre study to investigate the endometrial safety of Menofem® FCT during 52 weeks of administration in post-menopausal women suffering from symptoms related to estrogen deficiency.

    Study Document Trial synopsis 563.3 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.